Medtronic, Inc. (NYSE: MDT) announced that it has reached a global patent settlement agreement with Edwards Lifesciences Corporation (NYSE: EW).Under ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Litigation Management Comments

Medtronic (MDT) / Edwards Lifesciences (EW) Settlement Seen as Win-Win - Deutsche BankMay 20, 2014 1:18 PM Medtronic (MDT) Receives CE Mark for NC EuphoraMay 20, 2014 11:15 AM Medtronic, Inc. (MDT) Reports In-Line Q4 EPS; Guides FY15May 20, 2014 7:19 AM